WITNESS software leads to success for Sanofi

September 4, 2009
Stephanie Sutton

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

Sanofi aventis has finished implementing Lanner's process simulation software into one of its major UK sites following a successful Phase I implementation in which the company made more than £1 million in inventory cost savings in 6 months.

Sanofi aventis has finished implementing Lanner's process simulation software into one of its major UK sites following a successful Phase I implementation in which the company made more than £1 million in inventory cost savings in 6 months.

The simulation software, WITNESS, enables companies to simulate business decisions and to understand any process. According to Lanner, the software has been used in a variety of sectors including pharmaceutical, energy, nuclear and criminal justice.

In a press statement, Trevor Norman, Continuous Improvement Manager at sanofi-aventis, said: "With the help of Lanner, we simulated a virtual model of our production lines with the new production methods accounted for, and provided us with the data we needed to maximize production efficiency, which in turn reduced our inventory by a massive £1.4 million (1.6 million euro) in the first 6 months alone."

Speaking exclusively to Pharmaceutical Technology Europe, David Jones, CEO of Lanner, explained: "In today's fast-paced environments, organizations require solutions that are easy to use and facilitate a fast return on their investment to drive efficiency gains and streamline their business processes. To help achieve this, organizations are increasingly turning to process simulation technology. Through mapping out business process change in a virtual environment, organizations can ascertain the most effective approach, de-risk decisions and drive down costs while boosting productivity."

www.lanner.com